MuKiLOG: Long-term Outcome After Gestational Diabetes and Diabetes in Pregnancy

Sponsor
Jena University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04417452
Collaborator
(none)
100
1
28
3.6

Study Details

Study Description

Brief Summary

The primary objectives of the proposed project are to assess the long-term effects of prenatal exposure to gestational diabetes or diabetes on the maturation and health of the offspring. In addition, the long-term changes on the health of the affected mothers will be investigated, taking into account the metabolic adjustment during index pregnancy. The expected results will help to establish possible prevention strategies to fight the epidemic of non-communicable diseases for the offspring and the mothers.

Condition or Disease Intervention/Treatment Phase
  • Other: Basic data collection (online survey or written form)
  • Other: Physical examination
  • Behavioral: Psychometric examination
  • Diagnostic Test: Recording of the adrenergic stress reaction (saliva test)

Detailed Description

Investigation of the long-term outcome of mother-child pairs after diabetic pregnancies and a comparison group regarding metabolic, cardiovascular, neurocognitive and reproductive long-term changes as a function of the course of pregnancy and metabolic control

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Effects of Fetal Programming on the Metabolic, Cardiovascular, Neurocognitive and Reproductive Health of Offsprings and Their Mothers After Pregnancies With Diabetes
Actual Study Start Date :
Sep 1, 2019
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Mothers / children after diabetes in pregnancy

The study collective is composed of mother-child pairs after gestational diabetes, which were supervised in the Competence Center for Diabetes and Pregnancy at the University Hospital of Jena. The patients can decide to fill in an online questionnaire. For all other parts of the study, only patients who have been informed individually or on behalf of their legal guardian about the nature of the study after a detailed and understandable explanatory discussion with an investigator and who have given written consent will be included in the study.

Other: Basic data collection (online survey or written form)
Basic data collection is carried out by means of a questionnaire that participants can fill in outside the study centre. It contains questions about the current life situation, sleep and activity behaviour.

Other: Physical examination
The physical examination takes place at the study centre and includes the measurement of height, current weight and body fat, as well as the recording of heart and circulation parameters (e.g. blood pressure measurement or determination of vascular health by means of ultrasound). General metabolic and hormonal parameters are analysed by means of a blood sample. In addition, a sugar test for diabetes diagnosis will be carried out.

Behavioral: Psychometric examination
Psychometric examination is carried out at the study centre with the help of a RIAS test.

Diagnostic Test: Recording of the adrenergic stress reaction (saliva test)
The adrenergic stress reaction is recorded by a saliva test.

Controls

The control collective is composed of mother-child pairs who were cared for at the same time as the study collective at the University Hospital Jena. This collective is status post singleton pregnancy and term birth. The patients can decide to fill in an online questionnaire. For all other parts of the study, only patients who have been informed individually or on behalf of their legal guardian about the nature of the study after a detailed and understandable explanatory discussion with an investigator and who have given written consent will be included in the study.

Other: Basic data collection (online survey or written form)
Basic data collection is carried out by means of a questionnaire that participants can fill in outside the study centre. It contains questions about the current life situation, sleep and activity behaviour.

Other: Physical examination
The physical examination takes place at the study centre and includes the measurement of height, current weight and body fat, as well as the recording of heart and circulation parameters (e.g. blood pressure measurement or determination of vascular health by means of ultrasound). General metabolic and hormonal parameters are analysed by means of a blood sample. In addition, a sugar test for diabetes diagnosis will be carried out.

Behavioral: Psychometric examination
Psychometric examination is carried out at the study centre with the help of a RIAS test.

Diagnostic Test: Recording of the adrenergic stress reaction (saliva test)
The adrenergic stress reaction is recorded by a saliva test.

Outcome Measures

Primary Outcome Measures

  1. Metabolic health [1 day examination at the study centre]

    effects on metabolic health such as glucose tolerance disorders and diabetes mellitus, obesity and metabolic syndrome (mothers and children)

  2. Neurocognitive development [1 day examination at the study centre]

    effects on neurocognitive development, mental health and adrenal and autonomic stress reactivity (mothers and children)

  3. Cardiovascular and vascular health [1 day examination at the study centre]

    effects on cardiovascular and vascular health of blood pressure regulation and endothelial function (mothers and children)

  4. Maturation of the gonadal regulation [1 day examination at the study centre]

    maturation of gonadal regulation, pubertal development and reproductive health (children)

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • For the pilot project: Initial participation in the preliminary study

  • Written Informed Consent

  • Singleton pregnancies

  • Delivery at the University Hospital Jena

Exclusion criteria:
  • Severe physical and mental illness

  • Patients who refuse to participate in the study or drop out

  • Premature birth, i.e. birth of the child <37/0 SSW

  • Serious pregnancy complications

  • Prenatally known serious malformations

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitätsklinikum Jena Jena Thüringen Germany 07747

Sponsors and Collaborators

  • Jena University Hospital

Investigators

  • Principal Investigator: Friederike Weschenfelder, Dr. med., Klinik für Geburtsmedizin

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jena University Hospital
ClinicalTrials.gov Identifier:
NCT04417452
Other Study ID Numbers:
  • 2019-1403
First Posted:
Jun 4, 2020
Last Update Posted:
Aug 27, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 27, 2021